Bcl-2 and Mcl-2 anti-apoptosis proteins are up-regulated in the FLS of RA patients, indicating that apoptosis is inhibited in the development of RA, and how to effectively promote FLS apoptosis and inhibit synovial proliferation has important clinical implications for RA treatment (165). The gene discussed is BCL2; the disease is rheumatoid arthritis.